The results indicated that lncRNA CRAL could sponge miRNA-505 to upregulate the cylindromatosis gene (CYLD) expression, which subsequently inhibited AKT activation and resulted in an enhancement in the sensitivity of GC cells to DDP 71. The gene discussed is AKT1; the disease is gastric cancer.